Zobrazeno 1 - 10
of 25
pro vyhledávání: '"T J, Wilt"'
Publikováno v:
Journal of Urology. 203:1219-1221
Publikováno v:
The Journal of Urology. :1526-1532
Publikováno v:
The Cochrane database of systematic reviews. (2)
Five-alpha-reductase inhibitors (5ARI) are frequently used to treat bothersome lower urinary tract symptoms associated with benign prostatic hyperplasia and male androgenic alopecia. They have potential as chemopreventive agents.We sought to estimate
Autor:
T J, Wilt, D, Niewoehner, C, Kim, R L, Kane, A, Linabery, J, Tacklind, R, Macdonald, I, Rutks
Publikováno v:
Evidence report/technology assessment (Summary). (121)
Publikováno v:
BJU international. 92(4)
To determine the efficacy and safety of trazodone in the treatment of erectile dysfunction (ED) in a meta-analysis.The data sources used were Medline and the Cochrane Library databases (January 1966 to May 2002), bibliographies of retrieved articles
Publikováno v:
The Cochrane database of systematic reviews. (3)
Tumour recurrence following transurethral resection (TUR) for Ta and T1 bladder cancer is a major clinical problem. Intravesical administration of mitomycin C (MMC) or bacillus Calmette-Guerin (BCG) has proven prophylactic activity but both are assoc
Publikováno v:
The Cochrane database of systematic reviews. (1)
Benign prostatic hyperplasia (BPH) is a nonmalignant enlargement of the prostate which can result in bothersome lower urinary tract symptoms. The treatment goal for men with BPH is to relieve these bothersome symptoms.This systematic review assessed
Publikováno v:
The Cochrane database of systematic reviews. (4)
Lower urinary tract symptoms associated with benign prostatic obstruction (BPO) occur in up to 70% of men over the age of 60 years. To relieve these bothersome symptoms, treatment options include alpha-antagonists, also know as alpha-blockers.We cond
Publikováno v:
BJU international. 89(3)
To systematically review and evaluate the effectiveness and adverse effects of the alpha-antagonist, terazosin, for treating urinary symptoms associated with benign prostatic obstruction (BPO).Studies were sought and included in the review if they we
Autor:
T J, Wilt, M K, Brawer
Publikováno v:
Praxis. 90(36)